Showing results (2271-2280 of 3,888) with videos related to

Sort By:
Pageof 389
Cancer Biology & Therapy|February 22, 2014
Anti-EGFR therapeutic efficacy correlates directly with inhibition of STAT3 activityNelson Ung, Tracy L Putoczki, Stanley S Stylli, et al.
Cancer Biology & Therapy|February 22, 2014
Mice lacking G0S2 are lean and cold-tolerantTian Ma, Alexandra G N Lopez-Aguiar, Aihua Li, et al.
Cancer Biology & Therapy|February 22, 2014
Study design and clinical evidence in mRCC: can we save axitinib as a first-line therapy?Roberto Iacovelli, Elena Verzoni, Filippo Maria De Braud, et al.
Cancer Biology & Therapy|February 22, 2014
Lifespan extension and cancer prevention in HER-2/neu transgenic mice treated with low intermittent doses of rapamycinIrina G Popovich, Vladimir N Anisimov, Mark A Zabezhinski, et al.
Cancer Biology & Therapy|April 14, 2017
Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastomaAnnalisa Pezzolo, Angela Rita Sementa, Margherita Lerone, et al.
Cancer Biology & Therapy|May 20, 2008
JSI-124 inhibits glioblastoma multiforme cell proliferation through G(2)/M cell cycle arrest and apoptosis augmentYuhang Su, Gang Li, Xulong Zhang, et al.
Cancer Biology & Therapy|April 17, 2008
Downregulation of c-jun results in apoptosis-mediated anti-osteosarcoma activity in an orthotopic modelCrispin R Dass, Anna M Friedhuber, Levon M Khachigian, et al.
Cancer Biology & Therapy|August 24, 2019
C7 peptide inhibits hepatocellular carcinoma metastasis by targeting the HGF/c-Met signaling pathwayMingyuan Zhao, Yinhe Wang, Yan Liu, et al.
Cancer Biology & Therapy|April 2, 2019
EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathwayTing Lei, Xiaodong Zhu, Kai Zhu, et al.
Cancer Biology & Therapy|May 19, 2015
The interplay between DNA repair and autophagy in cancer therapyDan Zhang, Bo Tang, Xia Xie, et al.
Pageof 389